Article Text

Download PDFPDF

Meeting the need for corrective spectacles in visually impaired Chinese school children: the potential of ready-made spectacles
  1. Zhuoting Zhu1,
  2. Leon B Ellwein2,
  3. Sean K Wang3,
  4. Jialiang Zhao4,
  5. Mingguang He1,5
  1. 1 State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
  2. 2 National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
  3. 3 Harvard Medical School, Boston, Massachusetts, USA
  4. 4 Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China
  5. 5 Department of Surgery, Centre for Eye Research Australia; Ophthalmology, University of Melbourne, Melbourne, Victoria, Australia
  1. Correspondence to Dr Mingguang He, Zhongshan Ophthalmic Center, People’s Republic of China, Guangzhou 510060, China; mingguanghe{at}gmail.com; Professor Jialiang Zhao, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China; 13501132676{at}163.com

Abstract

Purpose To assess the potential of ready-made (spherical) spectacles (RMS) in meeting the need for refractive correction in visually impaired children in China.

Methods Eligible children aged 5–17 years were identified from the three study sites in China. Distance visual acuity was measured with a retroilluminated logarithm of the minimum angle of resolution chart with tumbling E optotypes. Cycloplegic autorefraction was performed on all children using a handheld autorefractor. If uncorrected visual acuity (UCVA) was ≤20/40 in either eye, best corrected visual acuity was measured with subjective refractive error.

Results A total of 13 702 children were enumerated from the three studies, with 12 334 (90.0%) having both reliable visual acuity measurements and successful cycloplegia. Among the 12 334 study children, the prevalence of UCVA ≤20/40 in the better seeing eye was 16.4% (95% CI 15.0% to 17.8%), with 91.1% (1843) of these improving by ≥3 lines of visual acuity with refractive correction. Prevalence was 12.7% (95% CI 11.5% to 13.9%) for UCVA <20/50 with 97.4% (1521) improving by ≥3 lines, and 9.38% (95% CI 8.39% to 19.4%) for UCVA ≤20/63 with 98.4% (1138) improving by ≥3 lines. Depending on the severity of visual impairment, 62.8%–64.0% of children could be accommodated with RMS if not correcting for astigmatism of ≤0.75 dioptres and anisometropia of ≤0.50 spherical equivalent dioptres. Approximately 87% of children could be accommodated with RMS if astigmatism and anisometropia limits were increased to ≤1.25 and ≤1.50 dioptres, respectively.

Conclusions RMS could substantially alleviate visual morbidity in two-thirds or more of visually impaired schoolchildren in China. This cost-effective approach to refractive correction might also be useful in low/middle-income countries with poor access to optometric services.

  • vision
  • rehabilitation
  • public health
  • optics and refraction

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors Conception and design (JZ, MH); data collection (JZ, MH); analysis and interpretation (ZZ, LBE, SKW, JZ, MH); writing of the article (ZZ, LBE); critical revision of the article (SKW, JZ, MH).

  • Funding The present work was supported by the World Health Organization under National Institutes of Health contract N01-EY-2103, the Fundamental Research Funds of the State Key Laboratory in Ophthalmology, and the National Natural Science Foundation of China (81125007). MH receives support from the University of Melbourne at Research Accelerator Program and the CERA Foundation. The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian State Government.

  • Disclaimer The sponsor or funding organisation had no role in the design or conduct of this research.

  • Competing interests None declared.

  • Patient consent Parental/guardian consent obtained.

  • Ethics approval WHO Secretariat Committee on Research Involving Human Subjects.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles

  • At a glance
    Keith Barton Jost B Jonas James Chodosh